Right to Try in Oman
How the right to try pathway operates in Oman.
About Right to Try
US federal legislation (2018) providing an alternative pathway to investigational drugs.
How Right to Try works in Oman
Oman's MoH operates a personal-import pathway; volumes are smaller but the pathway is functional for rare-disease and specialty needs.
Patients in Oman seeking access under Right to Try typically follow this flow: a licensed physician in Oman issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Oman
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 2 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.